CD34+ acute myeloid leukemia cells with low levels of reactive oxygen species show increased expression of stemness-genes and can be targeted by the BCL2 inhibitor Venetoclax

Katharina Mattes, Mylène Gerritsen, Hendrik Folkerts, Marjan Geugien, Fiona A van den Heuvel, Arthur Flohr Svendsen, Guoqiang Yi, Joost H A Martens, Edo Vellenga*

*Corresponding author for this work

    Research output: Contribution to journalArticleAcademicpeer-review

    8 Citations (Scopus)
    120 Downloads (Pure)
    Original languageEnglish
    Pages (from-to)e399-e403
    Number of pages5
    JournalHaematologica
    Volume105
    Issue number8
    Early online date14-Nov-2019
    DOIs
    Publication statusPublished - 1-Aug-2020

    Keywords

    • RESISTANCE

    Cite this